Blood
Издатель: Elsevier · ISSN 0006-4971 · 75 статей
- Don’t rush it: early CNI exposure derails tolerance
- Combining quizartinib with intensive chemotherapy for older patients with newly diagnosed AML: results of the UK NCRI AML18 trial
- Expansion of functional human long-term HSCs through restraining excessive cell cycle activation
- Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression
- MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
- Boosting antileukemia cytotoxicity of CD4 and CD8 T cells through combined inhibition of MEK and HDAC
- FERMT3 alternative splicing enhances kindlin-3 membrane recruitment for neutrophil adhesion during stress myelopoiesis
- Factor VIII Aurora: a naturally occurring gain-of-function FVIII variant with enhanced FIXa affinity
- Early administration of calcineurin inhibitors limits the tolerogenic effect of PTCy in allogeneic hematopoietic transplant
- Choi HR, Piao H, Atriardi SR, et al. Selective depletion of ABO-responsive B cells by T-cell–engaging bispecific antibody conjugates for ABOi transplantation. Blood. 2026;147(17):1928-1940.
- Negrin RS, Meyer EH. CD4+CD25+FOXP3+ regulatory T cells to protect against graft-versus-host disease. Blood. 2026;148(11):1381-1387.
- How I Treat Hypereosinophilic Syndrome with Eosinophil-Targeting Biologics
- Multimodal omics identifies a lymphoid-biased multipotent progenitor population with limited age-associated remodeling
- CD20-directed Autologous CAR T-cell Therapy for Waldenström Macroglobulinemia
- Mechanistically distinct classes of BCR::ABL1 mutations confer resistance to asciminib
- Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm
- Upfront whole genome and transcriptome sequencing to improve diagnosis in inherited bone marrow failure syndromes
- Detection, monitoring, and discrimination of amyloidogenic vs innocent light chains in systemic amyloidoses
- International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia
- Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients
- Nuclear Receptor Nur77 Orchestrates Hematopoietic Lineage Commitment to Avert Anemia in Diabetes
- Pivekimab sunirine and the evolving treatment of blastic plasmacytoid dendritic cell neoplasm
- Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?
- The Pathogen Recognition Receptor RIG-I is Functional in Platelets and Limits Thrombotic Responses
- Table of Contents
- Editorial Board
- Fit for the fight: BTK inhibitors prime CAR T cells in CLL
- The new Iron Age in polycythemia vera
- Beyond provoked and unprovoked: guiding clinical decisions
- Correcting a genetic overSTATement